Variant report
Variant | esv32555 |
---|---|
Chromosome Location | chr7:7986944-7988232 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000106415 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556641525 | chr7:7986966-7986967 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs574866386 | chr7:7986971-7986972 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs542232312 | chr7:7987036-7987037 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs554179975 | chr7:7987086-7987087 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs573034748 | chr7:7987093-7987094 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs540569567 | chr7:7987104-7987105 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs543869355 | chr7:7987107-7987108 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs532341971 | chr7:7987129-7987130 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs17140599 | chr7:7987137-7987138 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs529192925 | chr7:7987139-7987140 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs140830325 | chr7:7987145-7987146 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs181735975 | chr7:7987200-7987201 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs145750915 | chr7:7987345-7987346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187179162 | chr7:7987353-7987354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561361107 | chr7:7987359-7987360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs77319294 | chr7:7987387-7987388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377756355 | chr7:7987388-7987389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547312007 | chr7:7987414-7987415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571702633 | chr7:7987534-7987535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547520217 | chr7:7987587-7987588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538868610 | chr7:7987643-7987644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550227504 | chr7:7987667-7987668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568597728 | chr7:7987670-7987671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144743095 | chr7:7987728-7987729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146766823 | chr7:7987810-7987811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575122399 | chr7:7987819-7987820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551043537 | chr7:7987853-7987854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79686164 | chr7:7987871-7987872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372588996 | chr7:7987876-7987877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577081595 | chr7:7987884-7987885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10255002 | chr7:7987940-7987941 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs562705957 | chr7:7987948-7987949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6961526 | chr7:7987993-7987994 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs377607937 | chr7:7987998-7987999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10224801 | chr7:7988012-7988013 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs561116369 | chr7:7988048-7988049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528490739 | chr7:7988074-7988075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536621978 | chr7:7988085-7988086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12670535 | chr7:7988091-7988092 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs192106870 | chr7:7988128-7988129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35657099 | chr7:7988187-7988188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs6947392 | chr7:7988212-7988213 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:7984200-7987200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr7:7984400-7995600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr7:7984400-7996200 | Weak transcription | Left Ventricle | heart |
4 | chr7:7984800-7996800 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
5 | chr7:7985000-7987000 | Enhancers | Thymus | Thymus |
6 | chr7:7985000-7991200 | Weak transcription | Primary hematopoietic stem cells | blood |
7 | chr7:7985000-8003800 | Weak transcription | Primary B cells from cord blood | blood |
8 | chr7:7985400-8007600 | Weak transcription | Psoas Muscle | Psoas |
9 | chr7:7985600-7990400 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
10 | chr7:7985800-7990200 | Enhancers | Dnd41 | blood |
11 | chr7:7986400-7989200 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
12 | chr7:7986800-7987800 | Weak transcription | Placenta | Placenta |
13 | chr7:7986800-7990200 | Weak transcription | Fetal Thymus | thymus |
14 | chr7:7986800-7994000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
15 | chr7:7986800-8007800 | Weak transcription | Ovary | ovary |
16 | chr7:7987000-7995000 | Weak transcription | Thymus | Thymus |
17 | chr7:7987200-7989800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr7:7987800-7988000 | Enhancers | Fetal Intestine Large | intestine |
19 | chr7:7987800-7988000 | Enhancers | Fetal Intestine Small | intestine |
20 | chr7:7987800-7988000 | Enhancers | Placenta | Placenta |
21 | chr7:7988000-7989000 | Weak transcription | Fetal Intestine Large | intestine |